4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-23-009448
Dake Benjamin T sold 10,283 shares at an average $16.28 ($167,416)
- Dake Benjamin T acquired 10,283 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,412 | $1.74 | $4,197 | 3,703 | D |
| 2023-06-06 | Exercise or conversion : show line 2 in the form 10b5-1 | +7,871 | $2.14 | $16,844 | 11,574 | D |
| 2023-06-06 | Sale : show line 3 in the form 10b5-1 | −10,268 | $16.28 | $167,161 | 1,306 | D |
| 2023-06-06 | Sale : show line 4 in the form 10b5-1 | −15 | $16.98 | $255 | 1,291 | D |
| Open-market sales · 10,283 sh · avg $16.28 · $167,416 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-06 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −905 | 6,339 | D |
| 2023-06-06 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −1,507 | 21,095 | D |
| 2023-06-06 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −1,018 | 22,405 | D |
| 2023-06-06 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −6,853 | 164,461 | D |
Loading xslF345X04/form4-06082023_060620.xml…